.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Novartis
Cantor Fitzgerald
Cerilliant
US Department of Justice
Colorcon
Healthtrust
US Army
Queensland Health

Generated: November 17, 2017

DrugPatentWatch Database Preview

NEOSAR Drug Profile

« Back to Dashboard

What is the patent landscape for Neosar, and when can generic versions of Neosar launch?

Neosar is a drug marketed by Teva Parenteral and Bedford and is included in two NDAs.

The generic ingredient in NEOSAR is cyclophosphamide. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-004Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION087442-005Mar 30, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-002Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION087442-001Feb 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-005Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-001Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION087442-004Jul 8, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-003Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION087442-003Feb 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION087442-002Feb 16, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
McKinsey
Novartis
Julphar
Boehringer Ingelheim
Colorcon
Deloitte
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot